Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian A Wilson

Showing results (1-10 of 819) with videos related to

Pageof 82
Sort By:
Nature Structural Biology|March 5, 2002
Don C. WileyIan A Wilson
Journal of Molecular Biology|October 19, 2021
Structural and Biochemical Characterization of Cysteinylation in Broadly Neutralizing Antibodies to HIV-1Oluwarotimi Omorodion, Ian A Wilson
Journal of Virology|March 4, 2011
Structural characterization of an early fusion intermediate of influenza virus hemagglutininRui Xu, Ian A Wilson
Vaccines|May 25, 2024
The D Gene in CDR H3 Determines a Public Class of Human Antibodies to SARS-CoV-2Meng Yuan, Ian A Wilson
Immunological Reviews|December 28, 2024
Structural Immunology of SARS-CoV-2Meng Yuan, Ian A Wilson
Structure (London, England : 1993)|July 7, 2023
Major classes of neutralizing antibodies evaded by the SARS-CoV-2 Omicron variantMeng Yuan, Ian A Wilson
Immunological Reviews|May 22, 2022
Protective neutralizing epitopes in SARS-CoV-2Hejun Liu, Ian A Wilson
Cell Cycle (Georgetown, Tex.)|May 14, 2011
JAML and CAR: two more players in T-cell activationPetra Verdino, Ian A Wilson
Current Pharmaceutical Design|October 29, 2009
Presentation of lipid antigens by CD1 glycoproteinsAndré Schiefner, Ian A Wilson
Current Pharmaceutical Design|December 7, 2010
Structure-based vaccine design in HIV: blind men and the elephant?Robert Pejchal, Ian A Wilson
Pageof 82

Showing results (1-10 of 819) with videos related to

Sort By:
Pageof 82
Nature Structural Biology|March 5, 2002
Don C. WileyIan A Wilson
Journal of Molecular Biology|October 19, 2021
Structural and Biochemical Characterization of Cysteinylation in Broadly Neutralizing Antibodies to HIV-1Oluwarotimi Omorodion, Ian A Wilson
Journal of Virology|March 4, 2011
Structural characterization of an early fusion intermediate of influenza virus hemagglutininRui Xu, Ian A Wilson
Vaccines|May 25, 2024
The D Gene in CDR H3 Determines a Public Class of Human Antibodies to SARS-CoV-2Meng Yuan, Ian A Wilson
Immunological Reviews|December 28, 2024
Structural Immunology of SARS-CoV-2Meng Yuan, Ian A Wilson
Structure (London, England : 1993)|July 7, 2023
Major classes of neutralizing antibodies evaded by the SARS-CoV-2 Omicron variantMeng Yuan, Ian A Wilson
Immunological Reviews|May 22, 2022
Protective neutralizing epitopes in SARS-CoV-2Hejun Liu, Ian A Wilson
Cell Cycle (Georgetown, Tex.)|May 14, 2011
JAML and CAR: two more players in T-cell activationPetra Verdino, Ian A Wilson
Current Pharmaceutical Design|October 29, 2009
Presentation of lipid antigens by CD1 glycoproteinsAndré Schiefner, Ian A Wilson
Current Pharmaceutical Design|December 7, 2010
Structure-based vaccine design in HIV: blind men and the elephant?Robert Pejchal, Ian A Wilson
Pageof 82